Abstract
Surgical aortic valve replacement (SAVR) is the conventional treatment for patients with severe, symptomatic aortic valve stenosis. TAVI are less invasive procedures originally developed for patients with high surgical risks. The study aims to provide empirical evidence on the evolution of outcome performance measures in the use of TAVI between 2016 and 2020.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
